Hipotiroidismo en el paciente anciano: Importancia clínica y dificultades en el diagnóstico y tratamiento

Medicina Clinica

Volumn 111, Issue 19, 1998, Pages 742-750

  Díez, Juan J ^a,b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE SODIUM; THYROID HORMONE; THYROTROPIN;

ANGINA PECTORIS; AUTOIMMUNITY; DRUG EFFECT; ELDERLY CARE; HORMONE RELEASE; HUMAN; HYPOTHYROIDISM; REVIEW; THYROID FUNCTION;

AGED; AGING; AUTOIMMUNITY; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPOTHYROIDISM; THYROID GLAND; THYROXINE;

EID: 0032488395     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (166)

1. Campbell AJ, Reinken J, Allan BC. Thyroid disease in the elderly in the community. Age Ageing 1981; 10: 47-52.
2. Meyers B, Gionet M, Abreu C, Robuschi G, Pino S, Braverman L et al. Iodine intake probably affects the incidence of hypothyroidism and Hashimoto thyroids in elderly women. J Nucl Med 1986; 27: 909.
3. Sawin CT, Chopra D, Azizi F, Mannix JE, Bacharach P. The aging thyroid: increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA 1979; 242: 247-250.
4. Turnbridge WMG, Evered D, Hall R, Appleton D, Brewis M, Clark F et al. The spectrum of thyroid disease in a community: the Wickham survey. Clin Endocrinol (Oxford) 1977; 7: 481-493.
5. Bemben DA, Winn P, Hamm RM, Morgan L, Davis A, Barton E. Thyroid disease in the elderly. Part 1: prevalence of undiagnosed hypothyroidism. J Fam Pract 1994; 38: 577-582.
6. Luboshitzky R, Oberman AS, Kaufman N, Reichman N, Flatau E. Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population. Isr J Med Sci 1996; 32: 60-65.
7. Gambert SR, Escher JE. Atypical presentation of endocrine disorders in the elderly. Geriatrics 1988; 43: 69-71, 76-78.
8. Stuck LM, McFarland KF. Hypothyroidism in the elderly. When symptoms are not a «normal» part of aging. Postgrad Med 1991; 90: 141-143, 146.
9. Levy EG. Thyroid disease in the elderly. Med Clin North Am 1991; 75-151-167.
10. Campbell AJ. Thyroid disorders in the elderly. Difficulties in diagnosis and treatment. Drugs 1986; 31: 455-461.
11. Kabadi UM. Thyroid disorders and the elderly. Compr Ther 1989; 15: 53-65.
12. Rosenthal MJ, Sánchez CJ. Thyroid disease in the elderly: missed diagnosis or over diagnosis? West J Med 1985; 143: 643-647.
13. Shetty KR, Duthie EH Jr. Thyroid disease and associated illness in the elderly. Clin Geriatr Med 1995; 11: 311-325.
14. Hurley JR. Thyroid disease in the elderly. Med Clin North Am 1983; 67: 497-515.
15. Feit H. Thyroid function in the elderly. Clin Geriatr Med 1988; 4: 151-161.
16. Winger JM, Hornick T. Age-associated changes in the endocrine system. Nurs Clin North Am 1996; 31: 827-844.
17. Gregerman RI, Gaffney GW, Shock NW. Thyroxine turnover in euthyroid man with special reference to changes in age. J Clin Invest 1962; 41: 2.065-2.074.
18. 1-syndrome in old age. Klin Wochenschr 1981; 59: 315-321.
19. Braverman LE, Dawber N, Ingbar SH. Observations concerning the binding of thyroid hormones in sera of normal subjects of varying ages. J Clin Invest 1966; 45: 1.273-1.279.
20. Jefferys PM, Farran HEA, Hoffenber F, Fraser PM, Hodkinson HM. Thyroid function tests in the elderly. Lancet 1972; 1: 924-927.
21. Utiger RD. Decreased extrathyroidal triiodothyronine production in nonthyroidal illness: benefit or harm? Am J Med 1980; 69: 807-810.
22. Rock RC. Interpreting thyroid tests in the elderly: updated guidelines. Geriatrics 1985; 40: 61-68.
23. Iovino M, Steardo L, Monteleone P. Impaired sensitivity of the hypothalamo-pituitary-thyroid axis to the suppressant effect of dexamethasone in elderly subiects. Psychopharmacology (Berl) 1991; 105: 481-484.
24. Cervantes-Covarrubias AL, Halabe-Cherem J, Nellen-Hummel H, Gordon-Barabejzyk F, Lifshitz-Guinzberg A. Pruebas de función tiroidea en ancianos sanos y enfermos. Gac Med Mex 1992; 128: 15-18.
25. Lipponi G, Cadeddu G, Lucantoni C, Gasparrini PM, Spazzafumo L, Gaetti R. Profilo degli ormoni tiroidei nell'invecchiamento: valutazione su di una popolazione anziana ospedalizzata. Minerva Endocrinol 1992; 17: 31-36.
26. Goichot B, Schlienger JL, Grunenberger F, Pradignac A, Sapin R. Thyroid hormone status and nutrient intake in the free living elderly. Interest of reverse triiodothyronine assessment. Eur J Endocrinol 1994; 130: 244-252.
27. Villareal DT, Morley JE. Trophic factors in aging: should older people receive hormonal replacement therapy? Drugs Aging 1994; 4: 492-509.
28. a ed. Vol. 1). Filadelfia: WB Saunders, 1989: 640-645.
29. Gómez JM, Virgili N, Navarro MA, Roca M, Montana E, Soler J. Estudio de los parámetros de función tiroidea y de la tirotropina en la enfermedad general no tiroidea. Med Clin (Barc) 1989; 92: 5-9.
30. Simons RJ, Simon JM, Demers LM, Santen RJ. Thyrod dysfunction in elderly hospitalized patients: effect of age and severity of illness. Arch Intern Med 1990; 150: 1.249-1.253.
31. Isley WL. Thyroid dysfunction in the severely ill and elderly. Forget the classic signs and symptoms. Postgrad Med 1993; 94: 111-118, 127-128.
32. Nogues R, Sitges-Serra A, Sancho JJ, Sanz F, Monne J, Girvent M et al. Influence of nutrition, thyroid hormones, and rectal temperature on inhospital mortality of elderly patients with acute illness. Am J Clin Nutr 1995; 61: 597-602.
33. Mooradian AD. Normal age-related changes in thyroid hormone economy. Clin Geriatr Med 1995; 11: 159-169.
34. Chopra IJ. Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 1997; 82: 329-334.
35. Rubenstem HA, Butler VP Jr, Werner SC. Progressive decrease in serum triiodothyronine concentrations with human aging: radioimmunoassay following extraction of serum. J Clin Endocrinol Metab 1973; 37: 247-253.
36. Bermúdez F, Surks MI. Oppenhemier JH. High incidence of decreased serum triiodothyronine concentrations in patients with nonthyroidal disease. J Clin Endocrinol Metab 1975; 41: 27-40.
37. Nicod P, Burger A, Stacheli V, Vallottorn MB. A radioimmunoassay for 3-3′-5-triiodothyronine in unextracted serum: method and clinical results. J Clin Endocrinol Metab 1976; 42: 823-829.
38. Demeesfer-Mirkine N, Kutnowski M, Futeral B, Brauman H, Corvilain J. Thyroid status in elderly sick patients. J Endocrinol Invest 1981; 4: 41-44.
39. Harman SM, Wehmann RE, Blackman MR. Pituitary-thyroid hormone economy in healthy aging men: basal indices of thyroid function and thyrotropin responses to constant infusion of thyrotropin releasing hormone. J Clin Endocrinol Metab 1984; 58: 320-326.
40. Jacques C, Schlienger JL, Kisnal C, Kuntzmann F, Sapin R. TRH-induced TSH and prolactin responses in the elderly. Age Ageing 1987; 16: 181-188.
41. Wainstein E, Castillo A, Pineda G. Problemas en el diagnóstico de la disfunció tiroidea del adulto mayor. Rev Med Chil 1990; 118: 405-413.
42. Snyder PJ, Utiger RD. Responses to thyrotropin releasing hormone in normal man. J Clin Endocrinol Metab 1972; 34: 380-385.
43. Ordene KW, Pan C, Barzel US, Surks MI. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma thyroid hormone concentrations in patients of advanced age. Metabolism 1983; 32: 881-888.
44. Nissinen A, Kivelä SL, Pekkanen J, Pitkänen L, Punsar S, Kaarsalo E et al. Thyroid function teats in elderly finnish men. Acta Med Scand 1986; 220: 63-69.
45. Kaiser FE. Variability of response to thyroid-releasing hormone in normal elderly. Age Ageing 1987; 16: 345-354.
46. Hershman JM, Pekary AE, Berg L, Solomon DH, Sawin CT. Serum thyrotropin and thyroid hormone levels in elderly and middle-aged euthyroid persons. J Arn Geriatr Soc 1993; 41: 823-828.
47. Pozzi A, Gadola M, Maira G, Candrina R. Valutazione della funzione liroidea in pazienti anziani sani ricoverati in due istituti genatrici. Recent Prog Med 1992; 83: 506-509.
48. Erfurth EV, Norden NE, Hedner P, Nilson A, Ek L. Nomal reference interval for thyrotropin response to thyroliberin: dependence of age, sex, free thyroxine index and basal concentrations of thyrotropin. Clin Chem 1984; 30: 196-199.
49. Snyder PJ, Uliger RD. Thyrotropin response to thyrotropin releasing hormore in normal females over forty. J Clin Endocrinol Metab 1972; 34: 1.096-1.098.
50. Azizi F, Vagenakis AG, Pontnay GI, Rapoport B, Ingbar SH, Braverman LE. Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone based on analyses of serum thyroxine, tri-iodothyronine and thyrotropin concentrations. N Engl J Med 1975; 292: 273-277.
51. Olsson T, Viitanen M, Hägg E, Asplund K, Grankvist K, Eriksson S et al. Hormones in «young» and «old» elderly: pituitary-thyroid and pituitary-adrenal axes. Gerontology 1989; 35: 144-152.
52. Van Coevorden A, Laurent E, Decoster C, Kerkhofs M, Neve P, Van Cauter E et al. Decreased basal and stimulated thyrotropin secretion in healthy elderly men. J Clin Endocrinol Metab 1989; 69: 177-185.
53. Finucane P, Rudra T, Hsu R, Newcombe R, Pathy MS, Scanlon MF et al. Thyrotropin response to thyrotropin releasing hormone in elderly patients with and without acute illness. Age Ageing 1991; 20: 85-89.
54. Hall R, Amos J, Gary R, Buxton RL. Thyroid-stimulating hormone response to synthetic thyrotrophin releasing hormone in man. Br Med J 1970; 2: 274-277.
55. Weksler ME, Schwab R. The immunogenetics of immune senescence. Exp Clin Immunogenet 1992; 9: 182-187.
56. Pinchera A, Mariotti S, Barbesino G, Bechi R, Sansoni P, Fagiolo U et al. Thyroid autoimmunity and ageing. Horm Res 1995; 43: 64-68.
57. Dingle PR, Ferguson A, Hern DB, Tubmen J, Hall R. The incidence of thyroglobulin antibodies and thyroid enlargement in a general practice in North East England. Clin Exp Immunol 1966; 1: 277-283.
58. Bastenie PA, Neve P, Bonnyns M, Vanhaelst L, Chailly M. Clinical and pathological significance of asymptomatic atrophic thyroiditis. A condition of latent hypothyroidism. Lancet 1967; 1: 915-919.
59. Couchman KG, Wigley RD, Prior IAM. Autoantibodies in the Carlerton populated survey. The prevalence of thyroid and gastric antibodies, antinuclear and rheumatoid factor in a probability based population sample. J Chron Dis 1970; 23: 45-53.
60. Barbato MP. Thyroid autoantibodies in an Australian community. Med J Aust 1978; 2: 511-512.
61. Hawkins BR, Cheah PS, Dawkins RL, Whittingham S, Burger HG. Patel Y et al. Diagnostic significance of thyroid microsomal antibodies in ran domly selected population. Lancet 1980; 2: 1.057-1.059.
62. Inada M, Nishikawa M, Kawai I. Hypothyroidism associated with positive results of the perchlorate discharge test in elderly patients. Am J Med 1983; 74: 1.010-1.015.
63. Sawin CT, Bigos ST, Land S, Bacharach P. The aging thyroid: relationship between elevated serum thyrotropin level and thyroid antibodies in elderly patients. Am J Med 1985; 79: 591-595.
64. Sundbeck G, Eden S, Jagenburg R, Lundberg PA, Lindstedt G. Prevalence of serum antithyroid peroxidase antibodies in 85-years-old women and men. Clin Chem 1995; 41: 707-712.
65. Salabe GB, Salabe Lotz H, Ilardi I, Petracca C, Bile K. Low preference of thyroid antibodies in a somalian population. J Clin Immunol 1982; 9: 55-60.
66. Gillis S, Kozak R, Durante M, Weksler ME. Immunological studies of aging. J Clin Invest 1981; 67: 937-942.
67. Lewis VM, Twomey JJ, Bealmear P, Goldstein G, Good RA. Age, thymic involution and circulating thymic hormone activity. J Clin Endocrinol Metab 1978; 47: 145-150.
68. Robuschi G, Safran M, Braverman LE, Gnudi A, Roti E. Hypothyroidism in the elderly. Endocr Rev 1987; 8: 142-153.
69. a ed. Vol. 1). Filadelfia. WB Saunders, 1989; 683-701.
70. Griffin JE. Hypothyroidism in the elderly. Am J Med Sci 1990; 299: 334-345.
71. Barzel US. Hypothyroidism. Diagnosis and management. Clin Geriatr Med 1995; 11: 239-249.
72. a ed.). Nueva York: McGraw-Hill, 1995; 435-519.
73. Hurley DL, Gharib H. Thyroid nodular disease: is it toxic or nontoxic, malignant on benign? Geriatrics 1995; 50: 24-31.
74. Rolla AR. Thyroid nodules in the elderly. Clin Geriatr Med 1995; 11: 259-269.
75. Bilous RW, Turnbridge WMG. The epidemiology of hypothyroidism-an update. Bailliére's Clin Endocrinol Metab 1988; 2: 531-540.
76. Diez JJ, Rodriguez JS, Gómez-Pan A. Hipertiroidismo en el anciano. En: Ribera Casado JM, editor. Clinicas Geriátricas, VI: velez y sistema endocrino. Madrid: Editores Médicos S.A., 1990; 49-61.
77. Bartuska DG. Thyroid disease in the elderly. Hosp Pract Off Ed 1991; 26: 85-89, 92, 95-102.
78. Gambert SR. Hyperthyroidism in the elderly. Clin Geriatr Med 1995; 11: 181-188.
79. Huysmans DA, Buijs WC, Van de Von MT, Van den Broek WJ, Kloppenborg PW, Hermus AR et al. Dosimelry and risk estimates of radioiodine therapy for large, multinedular goiters. J Nucl Med 1996; 37: 2.072-2.079.
80. Sawers JSA, Toft AD, Irvine WJ, Brown NS, Seth J. Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis. J Clin Endocrinol Metab 1980; 50: 226-228.
81. Halnan KE. Risk from radioiodine treatment of thyrotoxirosis. Br Med J 1983; 287: 1.821-1.822.
82. Becker DV, McConahey WM, Dobyns BM, Tompkins E, Sheline GE, Workman JB. The results of radioiodine treatment of hyperthyroidism. A preliminary report of the Thyrotoxicosis Therapy Follow-Up Study. En: Fellinger K, Höfer R, editores. Further advances in thyroid research. Viena: Verlag der Wiener Medizineschen Akademie. 1971; 603-609.
83. Finucane P, Anderson C. Thyroid disease in older patients: diagnosis and treatment. Drug Aging 1995; 6: 268-277.
84. Toft AD, Irvine WJ, Seth J, Hunter WM, Cameron EHD. Thyroid function in the long-term follow-up of patients treated with iodine-131 for thyrotoxicosis. Lancet 1975; 2: 575-578.
85. Sridama V, McCormick M, Kaplan EL, Fauchet R, De Groot LJ. Long-term follow-up of compensated low-dose - itherapy for Graves disease. N Engl J Med 1984; 311: 426-432.
86. Staffurth JS. Hypothyroidism following radioiodine treatment of thyrotoxicosis. J Royal Coll Physicians (Lond) 1987; 21: 55-57.
87. Tamai H, Suemastu H, Kurokawa N, Esaki M, Ikemi T, Matsuzuka F et al. Alterations in circulating thyroid hormones and thyrotropin after complete thyroidectomy. J Clin Endocrinol Metab 1979; 48: 54-58.
88. Maler WP, Derrick BM, Marks AD, Channick BJ, Au FC, Caswell HT. Long-term follow-up patients with Graves' disease treated by subtotal thyroidectomy. Am J Surg 1984; 147: 266-268.
89. Hay ID, Klee GG. Thyroid dysfunction. Encloctinol Metab Clin North Am 1988; 17: 473-509.
90. Sarapura VD, Samuels MH, Ridgway CE. Thyroid-stimulating hormone. En: Melmed S, editor. The pituitary. Cambridge, MA: Blackwell Science Inc., 1995: 187-229.
91. Abboud C. Anterior pituitary failure. En: Melmed S, editor. The pituitary. Cambridge, MA: Blackwell Science Inc., 1995: 342-410.
92. Allen EM, Appel MC, Braverman LE. The effect of iodide ingestion on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat. Endocrinology 1986; 118: 1.977-1.981.
93. Woeher KA. Iodine and thyroid disease. Med Clin North Am 1991; 75: 169-178.
94. Laurberg P. Iodine intake: what are we aiming at? J Clin Endocrinol Metab 1994; 79: 17-19.
95. Roti E, Robuschi G, Gardini E, Montermini M, Salvi M, Manfredi A et al. Comparison of methimazole, methimazole and sodium ipodate and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease. Clin Endocrinol (Oxford) 1988; 28: 305-314.
96. Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Lenziardi M, Ceccarelli C et al. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. Clin Endocrinol (Oxford) 1987; 26: 227-237.
97. Cooper DS. Antithyroid drugs. N Engl J Med 1984; 311: 1.353-1.362.
98. Gamberi SR. Atypical presentation of thyroid disease in the elderly. Geriatrics 1985; 40: 63-65, 68-69.
99. Schroffner WG. The aging thyroid in health and disease. Geriatrics 1987; 42: 41-43, 48-49, 52.
100. Afschrift M. Schildklierafwijkingen bij bejaarden. Tijdschr Gerontol Genatr 1990; 21:3-6.
101. Bahemuka M, Hodkinson HM. Screening for hypothyroidism in elderly inpatients. Br Med J 1975; 2: 601-603.
102. Tachman ML, Guthrie GP Jr. Hypothyroidism: diversity of presentation. Endocrine Rev 1984; 5: 456-465.
103. Klein I, Levey GS. Unusual manifestations of hypothyroidism. Arch Intern Med 1984; 144: 123-128.
104. Sendagorta Goimendio A, Elosua de Juan I, González Montalvo JI. Zurita Sepúlveda P. Edema periorbitano unilateral como primera manifestación de hipotiroidismo en el anciano Rev Esp Geriatr Gerontol 1989; 24: 105-107.
105. Diez JJ, Doforno RA, Iglesias P, Sastre J, Gomez-Pan A, Borbujo J. Anticardiolipin antibodies in autoimmune thyroid disease. J Clin Lab Imnunol 1993; 40: 125-134.
106. Riniker M, Tieche M, Lupi GA, Grob P, Studer H, Burgi H. Prevalence of various degrees of hypothyroidism among petients of a general mecical department. Clin Endocrinol (Oxford) 1981; 14: 64-74.
107. Evered DC, Ormston BJ, Smith PA, Hall R, Bird T. Grades of hypothyroidism. Br Med J 1973; 1: 657-662.
108. Tibaldi J, Barzel US. Thyroxine supplementation: method for the prevention of clinical hypothyroidism. Am J Med 1985; 79: 241-244.
109. Wiener R, Utiger RD, Lew R, Emerson CH. Age, sex and serum thyrotropin concentrations in primary hypothyroidism. Acta Endocrinol (Copenh) 1991; 124: 364-369.
110. Bastenie PA, Bonnyns M, Vanhaelst L. Grades of subclinical hypothyroidism in asymptomatic autommune thyroiditis revealed by the thyrotropin-releasing hormone test. J Clin Endocrinol Metab 1980; 51: 163-166.
111. Croxson MS, Ibbertson HK. Subclinical hypothyroidism. NZ Med J 1980; 91: 89-91.
112. Ridgway EC, Cooper DS, Walker H, Rodbard D, Maloof F. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 1981; 53: 1.238-1.242.
113. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 1984; 101: 18-24.
114. a ed. Vol. 1) Filadelfia: WB Saunders, 1989; 590-639.
115. Ehrman DA, Weinberg M, Sarne DH. Limitations of the use of a sensitive assay for serum thyrotropin in the assessment of thyroid status. Arch Intern Med 1989; 149: 369-372.
116. Arem R, Deppe S. Fatal nonthyroidal illness may impair nocturnal thyrotropin levels. Am J Med 1990; 88: 258-262.
117. Hamblin PS, Dyer SA, Mohr VS, Le Grand BA, Lim CF, Tuxen DV et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxmemia of critical illness. J Clin Endocrinol Metab 1986; 62: 717-722.
118. Chopra IJ. Nonthyroidal illness syndrome or euthyroid sick sindrome? Endocr Pract 1996; 2: 45-52.
119. Docter R, Krenning EP, de Jong M, Hennemann G. The sick euthyroid syndrome: change in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxford) 1993; 39: 499-518.
120. Brent GA, Hershman JM, Braunstein GD. Patients with severe nonthyroidal illness and serum thyrotropin concentrations in the hypothyroid range. Am J Med 1986; 81: 463-466.
121. Spencer CA. Clinical utility and cost-effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients. Mayo Clin Proc 1988; 63: 1.214-1.222.
122. Griffin JE. The dilemma of abnormal thyroid function tests: is thyroid disease present or not? Am J Med Sci 1985; 289: 76-88.
123. Van der Berthe G, De Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996; 24: 1.580-1.590.
124. Sawin CT. Geller A, Hershman JM, Castelli W, Bacharach P. The aging thyroid: the use of thyroid hormone in older persons. JAMA 1989; 261: 2.653-2.655.
125. Vanderpump MJP, Ahlquist JAO, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. Br Med J 1996; 313: 539-544.
126. Rosenbaum RL, Barzel US. Clinical hypothyroidism in the elderly: a preventable disorder? J Am Geriatr Soc 1981; 29: 221-223.
127. Rosembaun RL, Barzel US. Levothyroxine replacement dose for primary hypothyroidism decreases with age. Ann Intern Med 1982: 96: 53-55.
128. Young RE, Jones SJ, Bewsher PD, Hedley AJ. Age and the daily dose of thyroxine replacement therapy for hypothyroidism. Age Ageing 1984; 13: 293-303.
129. Drinka PJ, Nolten WE. Subclinical hypothyroidism in the elderly: to treat or not to treat? Am J Med Sci 1988; 295: 125-128.
130. Felicetta JV. Thyroid disease in the elderly Special features, changes in management. Postgrad Med 1988; 83: 145-146, 153-155, 159-160, 166.
131. Surks MI, Ocampo E. Subclinical thyroid disease. Am J Med 1996; 100: 217-223.
132. Levine HD. Compromise therapy in the patient with angina pectoris and hypothyroidism. Am J Med 1980; 69: 411-418.
133. Becker C. Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev 1985; 6: 432-440.
134. Aronow WS. The heart and thyroid disease. Clin Geriatr Med 1995; 11: 219-229.
135. Jackson IMD, Cobb WE. Why does anyone still use desiccated thyroid USP? Am J Med 1978; 64: 284-288.
136. Toft AD. Thyroxine replacement treatment: clinical judgement or biochemical control? Br Med J 1985; 291: 233-234.
137. Fish LH, Schwartz HL, Cavanaugh J, Steffer MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism, and bioavailabitity of levothyroxme in the treatment of hypothyroidism. N Engl J Med 1987; 316: 764-770.
138. Kabadi UM. Variability of L-thyroxine replacement dose in elderly patients with primary hypothyroidism. J Fam Pract 1987; 24: 473-477.
139. Spaulding SW. Age and the thyroid. Endocrinol Metab Clin North Am 1987; 16: 1.013-1.025.
140. Sawin CT, Herman T, Molitch ME, London MH, Kramer SM. Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med 1983; 75: 206-209.
141. Cunningham JJ, Barzel US. Lean body mass is a predictor of the daily requirement for thyroid hormone in older men and women. J Am Genatr Soc 1984; 32: 204-207.
142. Davis FB, LaMantia RS, Spaulding SW, Wehmann RE, Davis PJ. Estimation of a physiologic replacement dose of levothyroxine in elderly patients with hypothyroidism. Arch Intern Med 1984; 144: 1.752-1.754.
143. Maeda M, Kuzuya N, Masayama Y, Imai Y, Ikeda H, Uchimura H et al. Changes in serum triiodothyronine, thyroxine and thyrotropin during treatment with thyroxine in severe primary hypothyroidism. J Clin Endocrinol Metab 1976; 43: 10-17.
144. Stock JM, Surks MI, Oppenheimer JH. Replacement dosage of L-thyroxine in hypothyroidism: a re evaluation. N Engl J Med 1974; 290: 529-533.
145. Beringer T, McClements B, Weir I, Gilmore D, Kennedy L. Hypopituitarism in the elderly in the presence of elevated thyroid stimulating hormone levels. Postgrad Med J 1988; 64: 943-944.
146. Ross DS, Neer RM, Ridway EC, Daniels GH. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med 1987; 82: 1.167-1.170.
147. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clinm Endocrinol Metab 1996; 81:4.278-4.289.
148. Schneider DL, Barrett-Connor EL, Morton DL. Thyroid hormone use and bone mineral density in elderly men. Arch Intern Med 1995; 155: 2.005-2.007.
149. Gordin A, Lamberg BA. Spontaneous hypothyroidism in symptomless autoimmune thyroiditis. A long-term follow up study. Clin Endocrinol (Oxford) 1981; 15: 537-543.
150. Turnbridge WMG, Brewis M, French JM, Applelon D, Bird T, Clark F et al. Natural history of autoimmune thyroiditis. Br Med J 1981; 282: 258-262.
151. Editonal. Subclinical hypothyroidism. Lancet 1986; 1: 251-252.
152. Leslie PJ, Toft AD. The replacement therapy problem in hypothyrodism. Bailliere's Clin Endocrinol Metab 1988; 2: 653-669.
153. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up ot abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxford) 1991; 34: 77-83.
154. Rae P, Farrar J, Beckett G, Toft A. Assessment of thyroid status in elderly people. Br Med J 1993; 307: 177-180.
155. Bemben DA, Hamm RM, Morgan L, Winn P, Davis A, Barton E. Thyroid disease in the elderly. Part 2: predictability of subclinical hypothyroidism. J Fam Pract 1994; 38: 583-588.
156. Wiersinga WM. Subclinical hypothyroidism and hyperthyroidism, I: prevalence and clinical relevance. Neth J Med 1995; 46: 197-204.
157. Bastenie PA, Van Haelst L, Bonnyns M, Neve P, Staquet M. Preclinical hypothyroidism: a risk factor for coronary heart disease. Lancet 1971; 1: 204.
158. Althaus BU, Staub HB, Ryff de Leche A, Oberhansli A, Stahelin HB. LDL/HDL changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxford) 1988; 28: 157-163.
159. Rosenthal MJ, Hunt WC, Garry PJ, Goodwill JS. Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. JAMA 1987; 258: 209-213.
160. McBride JH, Thibeault RV, Rodgerson DO. Thyrotropin as measured by a sensitive immunoradiometric assay. Clin Chem 1985; 31: 1.865-1.867.
161. Rees-Jones RW, Rolla AR, Larsen PR. Hormonal content of thyroid replacement preparations. JAMA 1980; 243: 549-550.
162. Stoffer SS, Szpunar WE. Potency of brand name and generic levothyroxine products. JAMA 1980: 244: 1.704-1.705.
163. Sloffer SS, Szpunar WE. Potency of levothyroxine products. JAMA 1984; 251: 635-636.
164. Sawin CT, Surks MI, London M, Ranganathan C, Larsen R. Oral thyroxine: variation in biologic action and tablet content. Ann Intern Med 1984; 100: 641-645.
165. Escalada San Martín J, Ortego, Rojo J. Sánchez, Franco F. L-tiroxina sódica: variaciones en el contenido hormonal de tres preparados comerciales diferentes. Endocrinología 1994; 41: 13-16.
166. Peran S, Garriga MJ, Morreale de Escobar G, Asuncion M, Peran M. Increase in plasma thyrotropin levels in hypothyroid patients during treatment due to a defect in the commercial preparation. J Clin Endocrinol Metab 1997; 82: 3.192-3.195.